Cargando…
The Canadian Glomerulonephritis Registry (CGNR) and Translational Research Initiative: Rationale and Clinical Research Protocol
BACKGROUND: Glomerulonephritis (GN) is a leading cause of kidney failure and accounts for 20% of incident cases of end-stage kidney disease (ESKD) in Canada annually. Reversal of kidney injury and prevention of progression to kidney failure is possible; however, limited knowledge of underlying disea...
Autores principales: | Hildebrand, Ainslie M., Barua, Moumita, Barbour, Sean J., Tennankore, Karthik K., Cattran, Daniel C., Takano, Tomoko, Lam, Ping, De Serres, Sacha A., Samanta, Ratna, Hladunewich, Michelle A., Fairhead, Todd, Poyah, Penelope, Bush, D. Danielle, MacLaren, Brian, Sparkes, Dwight, Boll, Philip, Jauhal, Arenn, John, Rohan, Avila-Casado, Carmen, Reich, Heather N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016540/ https://www.ncbi.nlm.nih.gov/pubmed/35450151 http://dx.doi.org/10.1177/20543581221089094 |
Ejemplares similares
-
Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis
por: Jauhal, Arenn, et al.
Publicado: (2022) -
Focused Jurisdictional Scan of Glomerulonephritis Medication Access in Canada: A Program Report
por: Naipaul, Rohini, et al.
Publicado: (2023) -
Focal Segmental Glomerulosclerosis: Assessing the Risk of Relapse
por: Troyanov, Stéphan, et al.
Publicado: (2023) -
Management of Patients With Glomerulonephritis During the COVID-19 Pandemic: Recommendations From the Canadian Society of Nephrology COVID-19 Rapid Response Team
por: Moran, Sarah M., et al.
Publicado: (2020) -
Synthetic ACTH for Treatment of Glomerular Diseases: A Case
Series
por: Jauhal, Arenn, et al.
Publicado: (2022)